Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
The present invention provides a method of identifying a subject as having an increased risk of having or developing aggressive prostate cancer, comprising detecting in the subject the presence of various polymorphisms associated with an increased risk of having or developing aggressive prostate cancer.
1. A method of measuring a prostate specific antigen (PSA) level in a subject, comprising measuring the PSA level in a sample obtained from the subject identified as having the T allele of single nucleotide polymorphism rs4054823.
2. A method of measuring a prostate specific antigen (PSA) level in a subject, comprising:
a) obtaining a nucleic acid sample from the subject;
b) detecting the T allele of single nucleotide polymorphism rs4054823 in the nucleic acid sample by an amplification reaction, an amplification reaction with a single base extension, matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF-MS), sequencing, hybridization, restriction endonuclease digestion analysis, electrophoresis, or any combination thereof; and
c) measuring the PSA level in said subject.